Kelly Walblay

1.0k total citations
12 papers, 159 citations indexed

About

Kelly Walblay is a scholar working on Infectious Diseases, Epidemiology and Applied Microbiology and Biotechnology. According to data from OpenAlex, Kelly Walblay has authored 12 papers receiving a total of 159 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 5 papers in Epidemiology and 4 papers in Applied Microbiology and Biotechnology. Recurrent topics in Kelly Walblay's work include Antibiotic Use and Resistance (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Vaccine Coverage and Hesitancy (3 papers). Kelly Walblay is often cited by papers focused on Antibiotic Use and Resistance (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Vaccine Coverage and Hesitancy (3 papers). Kelly Walblay collaborates with scholars based in United States and Pakistan. Kelly Walblay's co-authors include Stéphanie Black, Stephanie Gretsch, Usha Samala, Hyeree Choi, Richard A. Teran, Livia Navon, Janna L. Kerins, Erin D. Moritz, Michael Wahl and Wiley D. Jenkins and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Infectious Diseases and Emerging infectious diseases.

In The Last Decade

Kelly Walblay

11 papers receiving 155 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelly Walblay United States 4 80 31 30 25 23 12 159
Amy K. Feehan United States 9 90 1.1× 25 0.8× 28 0.9× 3 0.1× 43 1.9× 16 280
Kavita Kothari Switzerland 6 88 1.1× 26 0.8× 30 1.0× 4 0.2× 10 0.4× 17 192
Victoria M. Gammino United States 9 258 3.2× 30 1.0× 248 8.3× 6 0.2× 11 0.5× 15 401
Abigail R. Cartus United States 8 75 0.9× 7 0.2× 83 2.8× 13 0.5× 11 0.5× 16 300
Sombo Fwoloshi Zambia 9 91 1.1× 13 0.4× 32 1.1× 7 0.3× 12 0.5× 25 172
Sione Crawford Australia 9 55 0.7× 22 0.7× 211 7.0× 7 0.3× 5 0.2× 24 297
Anna Palmer Australia 10 41 0.5× 18 0.6× 158 5.3× 2 0.1× 40 1.7× 15 262
Laura Edison United States 9 79 1.0× 2 0.1× 78 2.6× 22 0.9× 11 0.5× 17 258
Mazhgan Rowneki United States 9 131 1.6× 33 1.1× 40 1.3× 3 0.1× 14 0.6× 20 235
Manon Chaine Denmark 4 103 1.3× 54 1.7× 13 0.4× 11 0.4× 27 1.2× 5 143

Countries citing papers authored by Kelly Walblay

Since Specialization
Citations

This map shows the geographic impact of Kelly Walblay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Walblay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Walblay more than expected).

Fields of papers citing papers by Kelly Walblay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Walblay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Walblay. The network helps show where Kelly Walblay may publish in the future.

Co-authorship network of co-authors of Kelly Walblay

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Walblay. A scholar is included among the top collaborators of Kelly Walblay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Walblay. Kelly Walblay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Barbian, Hannah J., Kelly Walblay, Erin Newcomer, et al.. (2025). Genomic analysis of Candida auris transmission within an urban region. Microbial Genomics. 11(9).
2.
Walters, Maroya Spalding, Kiran M. Perkins, Joseph F. Perz, et al.. (2024). Characterizing Response Capacity of Healthcare-Associated Infection/Antimicrobial Resistance Programs — US, 2019–2022. SHILAP Revista de lepidopterología. 4(S1). s123–s123. 1 indexed citations
3.
Walblay, Kelly, Hira Adil, Kathryn Nelson, et al.. (2023). 1451. Elizabethkingia spp. Outbreak in a Ventilator-capable Skilled Nursing Facility, Chicago 2023. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
4.
Walblay, Kelly, et al.. (2023). Health Care Personnel Exposure Risk Assessment and Management During a Mpox Outbreak in Chicago, Illinois, 17 May to 8 July 2022. The Journal of Infectious Diseases. 229(Supplement_2). S207–S212. 1 indexed citations
5.
Teran, Richard A., Stephanie Gretsch, Kelly Walblay, et al.. (2023). SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020–2022. Emerging infectious diseases. 29(11). 2257–2265. 1 indexed citations
6.
Teran, Richard A., Kelly Walblay, Stephanie Gretsch, et al.. (2021). Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members — Chicago, Illinois, December 2020–March 2021. MMWR Morbidity and Mortality Weekly Report. 70(17). 632–638. 59 indexed citations
7.
Teran, Richard A., Kelly Walblay, Stephanie Gretsch, et al.. (2021). Postvaccination SARS-CoV-2 infections among skilled nursing facility residents and staff members — Chicago, Illinois, December 2020–March 2021. American Journal of Transplantation. 21(6). 2290–2297. 30 indexed citations
8.
McPherson, Tristan D., Kelly Walblay, Latania K. Logan, et al.. (2020). Notes from the Field: Candida auris and Carbapenemase-Producing Organism Prevalence in a Pediatric Hospital Providing Long-Term Transitional Care — Chicago, Illinois, 2019. MMWR Morbidity and Mortality Weekly Report. 69(34). 1180–1181. 2 indexed citations
9.
Pacilli, Massimo, et al.. (2020). Repeated Prevalence Surveys and Admission Screening for Candida auris at One Long-Term Acute-Care Hospital, Chicago, 2016–2019. Infection Control and Hospital Epidemiology. 41(S1). s14–s15. 2 indexed citations
10.
Pho, Mai T., Livia Navon, Kelly Walblay, et al.. (2019). Identifying Areas with Disproportionate Local Health Department Services Relative to Opioid Overdose, HIV and Hepatitis C Diagnosis Rates: A Study of Rural Illinois. International Journal of Environmental Research and Public Health. 16(6). 989–989. 22 indexed citations
11.
12.
Moritz, Erin D., Connie Austin, Michael Wahl, et al.. (2018). Notes from the Field: Outbreak of Severe Illness Linked to the Vitamin K Antagonist Brodifacoum and Use of Synthetic Cannabinoids — Illinois, March–April 2018. MMWR Morbidity and Mortality Weekly Report. 67(21). 607–608. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amy K. Feehan Breakdown of academic impact, for papers by Kavita Kothari Breakdown of academic impact, for papers by Victoria M. Gammino Breakdown of academic impact, for papers by Abigail R. Cartus Breakdown of academic impact, for papers by Sombo Fwoloshi Breakdown of academic impact, for papers by Sione Crawford Breakdown of academic impact, for papers by Anna Palmer Breakdown of academic impact, for papers by Laura Edison Breakdown of academic impact, for papers by Mazhgan Rowneki Breakdown of academic impact, for papers by Manon Chaine
Rankless by CCL
2026